Jul, 10 2026

Bioavailability Studies for Generics: What They Test and Why

Discover what bioavailability studies test to ensure generic drugs are safe and effective. Learn about AUC, Cmax, the 80-125% rule, and how FDA regulations protect your health.

Read More

Dec, 19 2025

Priority vs Standard Review: How FDA Prioritizes Generic Drug Applications

The FDA uses priority and standard review timelines to speed up or slow down generic drug approvals. Priority review cuts approval time to 8 months for first generics, shortage drugs, or improved formulations. A new pilot rewards U.S. manufacturing to strengthen supply chains.

Read More

Dec, 12 2025

How FDA Approval Costs for Generic Drugs Impact Healthcare Prices

FDA approval costs for generic drugs are high and complex, causing delays that keep prices up. Learn how regulatory fees, vague feedback, and policy changes impact access and savings - and what’s being done to fix it.

Read More